Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Apogee Therapeutics Inc. (APGE) had Weighted-Average Shares Outstanding (Basic) of 60.69M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-255.84M |
|
-- |
|
-- |
|
$285.60M |
|
$-285.60M |
|
$30.03M |
|
$-255.56M |
|
$-255.56M |
|
$-255.84M |
|
$-255.84M |
|
$-255.84M |
|
$-255.84M |
|
$-285.60M |
|
$-291.68M |
|
|
Weighted-Average Shares Outstanding (Basic) |
60.69M |
60.69M |
|
$-4.22 |
|
$-4.22 |
|
| Balance Sheet Financials | |
$741.36M |
|
$5.69M |
|
$195.78M |
|
$937.13M |
|
$27.91M |
|
-- |
|
$5.34M |
|
$33.25M |
|
$903.88M |
|
$903.88M |
|
$903.88M |
|
68.40M |
|
| Cash Flow Statement Financials | |
$-227.45M |
|
$-179.57M |
|
$396.49M |
|
$142.08M |
|
$131.55M |
|
$-10.53M |
|
$46.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
26.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-232.60M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-28.30% |
|
-28.30% |
|
-27.30% |
|
-28.30% |
|
$13.21 |
|
$-3.83 |
|
$-3.75 |
|